|
Market Closed -
Nasdaq
01:30:00 21/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.980 USD | +5.32% |
|
-0.50% | -42.77% |
| 25/08 | Grace Therapeutics Files for Resale of Up to 4.8 Million Shares | MT |
| 14/08 | Grace Therapeutics, Inc. Reports Impairment charges for the First Quarter Ended June 30, 2026 | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GRCE | Delayed | |
CBOE
| GRCE | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 2.1 | 3 | 3.18 |
| Spread/Res. | -5.71% | -34.00% | -37.74% |
| Spread/Supp. | +10.00% | +50.31% | +11.86% |
| Support | 1.8 | 1.317 | 1.77 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GRCE Stock
- Charts Grace Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
